348 related articles for article (PubMed ID: 19796244)
1. Antitumor immunity and cancer stem cells.
Schatton T; Frank MH
Ann N Y Acad Sci; 2009 Sep; 1176():154-69. PubMed ID: 19796244
[TBL] [Abstract][Full Text] [Related]
2. Modulation of T-cell activation by malignant melanoma initiating cells.
Schatton T; Schütte U; Frank NY; Zhan Q; Hoerning A; Robles SC; Zhou J; Hodi FS; Spagnoli GC; Murphy GF; Frank MH
Cancer Res; 2010 Jan; 70(2):697-708. PubMed ID: 20068175
[TBL] [Abstract][Full Text] [Related]
3. Identification of cells initiating human melanomas.
Schatton T; Murphy GF; Frank NY; Yamaura K; Waaga-Gasser AM; Gasser M; Zhan Q; Jordan S; Duncan LM; Weishaupt C; Fuhlbrigge RC; Kupper TS; Sayegh MH; Frank MH
Nature; 2008 Jan; 451(7176):345-9. PubMed ID: 18202660
[TBL] [Abstract][Full Text] [Related]
4. The helicase HAGE expressed by malignant melanoma-initiating cells is required for tumor cell proliferation in vivo.
Linley AJ; Mathieu MG; Miles AK; Rees RC; McArdle SE; Regad T
J Biol Chem; 2012 Apr; 287(17):13633-43. PubMed ID: 22393060
[TBL] [Abstract][Full Text] [Related]
5. Tumor initiation in human malignant melanoma and potential cancer therapies.
Ma J; Frank MH
Anticancer Agents Med Chem; 2010 Feb; 10(2):131-6. PubMed ID: 20184545
[TBL] [Abstract][Full Text] [Related]
6. Cancer stem cells: lessons from melanoma.
La Porta C
Stem Cell Rev Rep; 2009 Mar; 5(1):61-5. PubMed ID: 19093230
[TBL] [Abstract][Full Text] [Related]
7. ABCB5 maintains melanoma-initiating cells through a proinflammatory cytokine signaling circuit.
Wilson BJ; Saab KR; Ma J; Schatton T; Pütz P; Zhan Q; Murphy GF; Gasser M; Waaga-Gasser AM; Frank NY; Frank MH
Cancer Res; 2014 Aug; 74(15):4196-207. PubMed ID: 24934811
[TBL] [Abstract][Full Text] [Related]
8. Detection of ABCB5 tumour antigen-specific CD8
Borchers S; Maβlo C; Müller CA; Tahedl A; Volkind J; Nowak Y; Umansky V; Esterlechner J; Frank MH; Ganss C; Kluth MA; Utikal J
Clin Exp Immunol; 2018 Jan; 191(1):74-83. PubMed ID: 28940439
[TBL] [Abstract][Full Text] [Related]
9. VEGFR-1 expressed by malignant melanoma-initiating cells is required for tumor growth.
Frank NY; Schatton T; Kim S; Zhan Q; Wilson BJ; Ma J; Saab KR; Osherov V; Widlund HR; Gasser M; Waaga-Gasser AM; Kupper TS; Murphy GF; Frank MH
Cancer Res; 2011 Feb; 71(4):1474-85. PubMed ID: 21212411
[TBL] [Abstract][Full Text] [Related]
10. Stem cells and targeted approaches to melanoma cure.
Murphy GF; Wilson BJ; Girouard SD; Frank NY; Frank MH
Mol Aspects Med; 2014 Oct; 39():33-49. PubMed ID: 24145241
[TBL] [Abstract][Full Text] [Related]
11. Isolation of tumorigenic circulating melanoma cells.
Ma J; Lin JY; Alloo A; Wilson BJ; Schatton T; Zhan Q; Murphy GF; Waaga-Gasser AM; Gasser M; Stephen Hodi F; Frank NY; Frank MH
Biochem Biophys Res Commun; 2010 Nov; 402(4):711-7. PubMed ID: 20977885
[TBL] [Abstract][Full Text] [Related]
12. Aldehyde dehydrogenase-positive melanoma stem cells in tumorigenesis, drug resistance and anti-neoplastic immunotherapy.
Zhang S; Yang Z; Qi F
Mol Biol Rep; 2020 Feb; 47(2):1435-1443. PubMed ID: 31838656
[TBL] [Abstract][Full Text] [Related]
13. Parthenolide reduces the frequency of ABCB5-positive cells and clonogenic capacity of melanoma cells from anchorage independent melanospheres.
Czyz M; Koprowska K; Sztiller-Sikorska M
Cancer Biol Ther; 2013 Feb; 14(2):135-45. PubMed ID: 23192276
[TBL] [Abstract][Full Text] [Related]
14. Lessons from cancer immunoediting in cutaneous melanoma.
Aris M; Barrio MM; Mordoh J
Clin Dev Immunol; 2012; 2012():192719. PubMed ID: 22924051
[TBL] [Abstract][Full Text] [Related]
15. Targeting the ABC transporter ABCB5 sensitizes glioblastoma to temozolomide-induced apoptosis through a cell-cycle checkpoint regulation mechanism.
Lee CAA; Banerjee P; Wilson BJ; Wu S; Guo Q; Berg G; Karpova S; Mishra A; Lian JW; Tran J; Emmerich M; Murphy GF; Frank MH; Frank NY
J Biol Chem; 2020 May; 295(22):7774-7788. PubMed ID: 32317280
[TBL] [Abstract][Full Text] [Related]
16. Immune surveillance in melanoma: From immune attack to melanoma escape and even counterattack.
Mahmoud F; Shields B; Makhoul I; Avaritt N; Wong HK; Hutchins LF; Shalin S; Tackett AJ
Cancer Biol Ther; 2017 Jul; 18(7):451-469. PubMed ID: 28513269
[TBL] [Abstract][Full Text] [Related]
17. Differential expression of ABCB5 in BRAF inhibitor-resistant melanoma cell lines.
Xiao J; Egger ME; McMasters KM; Hao H
BMC Cancer; 2018 Jun; 18(1):675. PubMed ID: 29929490
[TBL] [Abstract][Full Text] [Related]
18. Cellular and molecular biology of cancer stem cells in melanoma: Possible therapeutic implications.
Marzagalli M; Raimondi M; Fontana F; Montagnani Marelli M; Moretti RM; Limonta P
Semin Cancer Biol; 2019 Dec; 59():221-235. PubMed ID: 31265892
[TBL] [Abstract][Full Text] [Related]
19. Natural killer cells kill human melanoma cells with characteristics of cancer stem cells.
Pietra G; Manzini C; Vitale M; Balsamo M; Ognio E; Boitano M; Queirolo P; Moretta L; Mingari MC
Int Immunol; 2009 Jul; 21(7):793-801. PubMed ID: 19491215
[TBL] [Abstract][Full Text] [Related]
20. ABCB5-mediated doxorubicin transport and chemoresistance in human malignant melanoma.
Frank NY; Margaryan A; Huang Y; Schatton T; Waaga-Gasser AM; Gasser M; Sayegh MH; Sadee W; Frank MH
Cancer Res; 2005 May; 65(10):4320-33. PubMed ID: 15899824
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
